Vitamin D3 metabolites regulate LTBP1 and latent TGF‐β1 expression and latent TGF‐β1 incorporation in the extracellular matrix of chondrocytes

Growth plate chondrocytes make TGF‐β1 in latent form (LTGF‐β1) and store it in the extracellular matrix via LTGF‐β1 binding protein (LTBP1). 1,25‐(OH)2D3 (1,25) regulates matrix protein production in growth zone (GC) chondrocyte cultures, whereas 24,25‐(OH)2D3 (24,25) does so in resting zone (RC) cell cultures. The aim of this study was to determine if 24,25 and 1,25 regulate LTBP1 expression as well as the LTBP1‐mediated storage of TGF‐β1 in the extracellular matrix of RC and GC cells. Expression of LTBP1 and TGF‐β1 in the growth plate and in cultured RC and GC cells was determined by in situ hybridization using sense and antisense oligonucleotide probes based on the published rat LTBP1 and TGF‐β1 cDNA sequences. Fourth passage male rat costochondral RC and GC chondrocytes were treated for 24 h with 10‐7‐10‐9 M 24,25 and 10‐8‐10‐10 M 1,25, respectively. LTBP1 and TGF‐β1 mRNA levels were measured by in situ hybridization; production of LTGF‐β1, LTGF‐β2, and LTBP1 protein in the conditioned media was verified by immunoassays of FPLC‐purified fractions. In addition, ELISA assays were used to measure the effect of 1,25 and 24,25 on the level of TGF‐β1 in the media and matrix of the cultures. Matrix‐bound LTGF‐β1 was released by digesting isolated matrices with 1 U/ml plasmin for 3 h at 37°C. LTBP1 and TGF‐β1 mRNAs are co‐expressed throughout the growth plate, except in the lower hypertrophic area. Cultured GC cells express more LTBP1 and TGF‐β1 mRNAs than RC cells. FPLC purification of the conditioned media confirmed that RC cells produce LTGF‐β1, LTGF‐β2, and LTBP1. GC cells also produce LTGF‐β2, but at lower concentrations. 1,25 dose‐dependently increased the number of GC cells with high LTBP1 expression, as seen by in situ hybridization. 24,25 had a similar, but less pronounced, effect on RC cells. 1,25 also caused a dose‐dependent increase in the amount of TGF‐β1 protein found in the matrix, significant at 10‐8 and 10‐9 M, and a corresponding decrease in TGF‐β1 in the media. 24,25 had no effect on the level of TGF‐β1 in the matrix or media produced by RC cells. This indicates that 1,25 induces the production of LTBP1 by GC cells and suggests that the TGF‐β1 content of the media is reduced through the formation of latent TGF‐β1‐LTBP1 complexes which mediates storage in the matrix. Although 24,25 induced the expression of LTBP1 by RCs, TGF‐β1 incorporation into the matrix is not regulated by this vitamin D3 metabolite. Thus, vitamin D3 metabolites may play a role in regulating the availability of TGF‐β1 by modulating LTBP1 production. J. Cell. Biochem. 72:151–165, 1999. © 1999 Wiley‐Liss, Inc.

[1]  B. Boyan,et al.  The synergistic effects of vitamin D metabolites and transforming growth factor-beta on costochondral chondrocytes are mediated by increases in protein kinase C activity involving two separate pathways. , 1998, Endocrinology.

[2]  X. Holy,et al.  TGF-beta2 prevents the impaired chondrocyte proliferation induced by unloading in growth plates of young rats. , 1997, Life sciences.

[3]  D. Burt,et al.  The expression of transforming growth factor-beta by cultured chick growth plate chondrocytes: differential regulation by 1,25-dihydroxyvitamin D3. , 1996, The Journal of endocrinology.

[4]  L. Bonewald,et al.  Characterization and regulation of the latent transforming growth factor‐β complex secreted by vascular pericytes , 1996, Journal of cellular physiology.

[5]  L. Bonewald,et al.  Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein , 1995, The Journal of cell biology.

[6]  L. Bonewald,et al.  Latent transforming growth factor-beta is produced by chondrocytes and activated by extracellular matrix vesicles upon exposure to 1,25-(OH)2D3. , 1994, The Journal of biological chemistry.

[7]  L. Bonewald,et al.  Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF beta-binding protein. , 1994, The Journal of biological chemistry.

[8]  M. Reed,et al.  TGF‐β1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors , 1994 .

[9]  K. Miyazono,et al.  Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein , 1994, The Journal of cell biology.

[10]  L. Bonewald,et al.  Direct effects of transforming growth factor-beta on chondrocytes are modulated by vitamin D metabolites in a cell maturation-specific manner. , 1993, Endocrinology.

[11]  E. Ruoslahti,et al.  Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease , 1992, Nature.

[12]  L. Bonewald,et al.  Effects of combining transforming growth factor beta and 1,25-dihydroxyvitamin D3 on differentiation of a human osteosarcoma (MG-63). , 1992, The Journal of biological chemistry.

[13]  B. Boyan,et al.  Production of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by growth zone and resting zone chondrocytes is dependent on cell maturation and is regulated by hormones and growth factors. , 1992, Endocrinology.

[14]  T. Colby,et al.  Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[15]  L. Bonewald,et al.  Latent Forms of Transforming Growth Factor-β (TGFβ) Derived from Bone Cultures: Identification of a Naturally Occurring 100-kDa Complex with Similarity to Recombinant Latent TGFβ , 1991 .

[16]  H. Moses,et al.  The beta-type transforming growth factor. Mediators of cell regulation in the lung. , 1990, The American review of respiratory disease.

[17]  G. Lust,et al.  Fibronectin and proteoglycan synthesis in long term cultures of cartilage explants in Ham's F12 supplemented with insulin and calcium: effects of the addition of TGF-beta. , 1990, Archives of biochemistry and biophysics.

[18]  K. Yamaguchi,et al.  Molecular cloning of the large subunit of transforming growth factor type beta masking protein and expression of the mRNA in various rat tissues. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  L. Bonewald,et al.  Stimulation of plasma membrane and matrix vesicle enzyme activity by transforming growth factor‐β in osteosarcoma cell cultures , 1990, Journal of cellular physiology.

[20]  E. Ruoslahti,et al.  Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. , 1990, The Journal of clinical investigation.

[21]  K. Miyazono,et al.  TGF-β1 binding protein: A component of the large latent complex of TGF-β1 with multiple repeat sequences , 1990, Cell.

[22]  L. Bonewald,et al.  Localization of 1,25-(OH)2D3-responsive alkaline phosphatase in osteoblast-like cells (ROS 17/2.8, MG 63, and MC 3T3) and growth cartilage cells in culture. , 1989, The Journal of biological chemistry.

[23]  B. Boyan,et al.  Effects of vitamin D metabolites on collagen production and cell proliferation of growth zone and resting zone cartilage cells in vitro , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  H. Marquardt,et al.  Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide , 1988, Molecular and cellular biology.

[25]  K. Miyazono,et al.  Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. , 1988, The Journal of biological chemistry.

[26]  B. Boyan,et al.  The effects of vitamin D metabolites on phospholipase A2 activity of growth zone and resting zone cartilage cells in vitro. , 1988, Endocrinology.

[27]  H. Moses,et al.  Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium , 1988, The Journal of cell biology.

[28]  D. Rosen,et al.  Transforming growth factor‐beta modulates the expression of osteoblast and chondroblast phenotypes in vitro , 1988, Journal of cellular physiology.

[29]  A. Brunner,et al.  Type 1 transforming growth factor beta: amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells , 1987, Molecular and cellular biology.

[30]  D. Rosen,et al.  Differentiation of rat mesenchymal cells by cartilage-inducing factor. Enhanced phenotypic expression by dihydrocytochalasin B. , 1986, Experimental cell research.

[31]  D. Wilkinson In situ hybridization: a practical approach , 1998 .

[32]  B. Boyan,et al.  The synergistic effect of TGF beta and 24,25-(OH)2D3 on resting zone chondrocytes is metabolite-specific and mediated by PKC. , 1996, Connective tissue research.

[33]  B. Boyan,et al.  Gender-related effects of vitamin D metabolites on cartilage and bone. , 1994, Bone and mineral.

[34]  B. Boyan,et al.  In vitro studies on the regulation of endochondral ossification by vitamin D. , 1992, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[35]  D. Carnes,et al.  Differential expression of phenotype by resting zone and growth region costochondral chondrocytes in vitro. , 1988, Bone.